A Phase 1 Study of CD6-CAR Tregs in Chronic Graft vs Host Disease
Suspended Phase 1 NCT05993611
Study Description
A Study of Engineered Immune Cells to Treat Chronic Graft vs Host Disease After Stem Cell Transplant
Study Details
- Registry ID:
- NCT05993611
- Conditions:
- Chronic Graft Versus Host Disease, Hematologic and Lymphocytic Disorder, Steroid Refractory Graft Versus Host Disease
- Phase:
- Phase 1
- Target Enrollment:
- 27 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
City of Hope Medical Center
Duarte, California, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.